The global Ureteral Stents Market was valued at approximately USD 528.8 million in 2025 and is projected to reach nearly USD 924.5 million by the end of 2035. The market is expected to expand at a CAGR of 6.5% during the forecast period from 2026 to 2035. The consistent rise in urinary tract disorders, increasing incidence of kidney stones, and growing demand for minimally invasive urological procedures are supporting the market’s long-term expansion.
Request Sample @ https://www.researchnester.com/sample-request-8031
Ureteral Stents Industry Demand
Ureteral stents are thin, flexible medical devices inserted into the ureter to maintain urine flow from the kidney to the bladder when obstruction occurs. These stents are widely used in urological surgeries, kidney stone management, ureteral strictures, postoperative drainage, and cancer-related urinary obstructions. The growing prevalence of urological disorders, particularly nephrolithiasis and urinary tract obstruction, has significantly increased the clinical demand for ureteral stents globally.
Ureteral Stents Market: Growth Drivers & Key Restraint
Growth Drivers –
Growth Driver 1: Rising Prevalence of Kidney Stones and Urinary Disorders
The increasing incidence of kidney stones, ureteral obstructions, and chronic urinary tract diseases remains one of the primary growth drivers for the ureteral stents market. Lifestyle changes, dehydration, obesity, and dietary habits have contributed to a growing global patient pool requiring urological intervention. Ureteral stents are commonly utilized before and after stone removal procedures, significantly boosting recurring procedural demand.
Growth Driver 2: Advancements in Stent Technology
Technological innovations in material science and device engineering are improving the effectiveness and comfort of ureteral stents. Manufacturers are developing hydrogel-coated, antimicrobial, biodegradable, and drug-eluting stents to reduce complications such as infections, migration, pain, and encrustation. These innovations are enhancing physician preference and increasing patient acceptance, particularly in long-term urinary management.
Growth Driver 3: Expansion of Minimally Invasive Urological Procedures
The rapid adoption of minimally invasive surgical techniques, including ureteroscopy and laser lithotripsy, has substantially increased the utilization of ureteral stents. Healthcare providers prefer minimally invasive interventions because they offer faster recovery, reduced trauma, lower hospitalization costs, and improved procedural efficiency. The expansion of advanced urology centers and ambulatory surgical facilities further supports market growth.
Restraint –
Despite significant technological progress, ureteral stents are still associated with complications such as discomfort, urinary tract infections, hematuria, migration, and encrustation. Long-term placement often requires repeat procedures for replacement or removal, increasing healthcare burden and affecting patient quality of life. These concerns may limit patient compliance and create challenges for widespread long-duration usage.
Ureteral Stents Market: Segment Analysis
Segment Analysis by Product Type –
Double-Pigtail Ureteral Stents
Double-pigtail ureteral stents represent one of the most widely used product categories due to their ability to prevent stent migration and maintain stable urine drainage. These stents are commonly utilized in postoperative care following stone removal procedures and ureteral surgeries. Their widespread clinical familiarity and effectiveness continue to support strong market demand across hospitals and specialty urology centers.
Open-End Ureteral Stents
Open-end ureteral stents are frequently preferred for easier guidewire access and improved drainage efficiency during complex urological interventions. These stents are commonly used in temporary urinary decompression procedures and diagnostic applications. Increasing adoption in advanced endoscopic surgeries is supporting segment expansion.
Closed-End Ureteral Stents
Closed-end stents are gaining traction in procedures where controlled drainage and reduced tissue trauma are critical. Improved patient comfort and reduced irritation associated with advanced closed-end designs are contributing to increased adoption among healthcare professionals.
Multiloop and Specialty Stents
Specialty ureteral stents, including multiloop and customized designs, are increasingly used in patients with chronic obstructions, malignancies, and anatomical complications. Technological advancements aimed at reducing encrustation and infection risks are accelerating growth in this segment, especially in tertiary care institutions.
Segment Analysis by Application –
Kidney Stone Management
Kidney stone management remains the dominant application segment in the ureteral stents market. Rising prevalence of nephrolithiasis worldwide and increasing ureteroscopy procedures continue to drive extensive stent utilization. Stents are commonly used to ensure ureteral patency before and after stone extraction procedures.
Urinary Incontinence and Obstruction Treatment
Ureteral stents are increasingly used to manage urinary obstructions caused by strictures, trauma, fibrosis, and malignancies. Growing incidence of obstructive uropathies among aging populations is supporting consistent procedural demand.
Post-Surgical Drainage
Postoperative drainage applications are witnessing strong growth due to the increasing volume of minimally invasive urological surgeries. Stents play a critical role in preventing complications such as swelling, blockage, and urine leakage after surgical intervention.
Cancer-Related Urological Conditions
The use of ureteral stents in oncology-related urinary obstruction management is expanding steadily. Patients with pelvic cancers frequently require long-term urinary drainage solutions, increasing demand for durable and infection-resistant stent technologies.
Segment Analysis by End‑User –
Hospitals
Hospitals account for the largest share of the ureteral stents market due to high patient inflow, availability of advanced surgical infrastructure, and growing number of urology specialists. Complex procedures and emergency urinary obstruction management are primarily conducted in hospital settings.
Ambulatory Surgical Centers
Ambulatory surgical centers are gaining market prominence owing to the growing preference for outpatient minimally invasive procedures. These facilities offer reduced treatment costs, shorter patient stays, and faster procedural turnaround, making them increasingly attractive for ureteral interventions.
Specialty Urology Clinics
Specialty urology clinics are witnessing rising adoption of ureteral stents due to increasing awareness regarding early diagnosis and treatment of urinary disorders. These clinics benefit from specialized expertise and improved patient management capabilities.
Ureteral Stents Market: Regional Insights
North America
North America represents a leading regional market for ureteral stents due to the high prevalence of kidney stones, advanced healthcare infrastructure, and strong adoption of minimally invasive urological procedures. The region benefits from favorable reimbursement systems, technological innovation, and the presence of major medical device manufacturers. Increasing elderly populations and growing awareness regarding urinary tract health continue to support regional demand.
Europe
Europe maintains a significant share of the global ureteral stents market owing to rising healthcare expenditure, increasing incidence of urological diseases, and expanding access to advanced treatment technologies. Countries across Western Europe are emphasizing early diagnosis and efficient management of urinary tract disorders. The growing adoption of biodegradable and antimicrobial stent technologies is also contributing to regional market growth.
Asia-Pacific (APAC)
Asia-Pacific is expected to witness the fastest growth in the ureteral stents market due to rapidly improving healthcare infrastructure, rising patient awareness, and increasing prevalence of kidney stone diseases. Expanding medical tourism, growing investments in hospital development, and rising adoption of minimally invasive procedures are creating strong market opportunities. Countries such as China, India, and Japan are emerging as important contributors to regional growth due to large patient populations and increasing healthcare accessibility.
Top Players in the Ureteral Stents Market
Major companies operating in the global Ureteral Stents Market include BD (Becton, Dickinson and Company), Teleflex Incorporated, Cook Medical, Stryker Corporation, and Medtronic plc. These companies are focusing on product innovation, strategic partnerships, expansion of urology portfolios, and development of advanced biocompatible stent technologies to strengthen their market presence globally.
Access Detailed Report @ https://www.researchnester.com/reports/ureteral-stents-market/8031
Research Nester Analytics is a leading service provider for strategic market research and consulting. We provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates, and executives make informed decisions regarding future marketing strategy, expansion, and investments. We believe every business can expand its horizon with the right guidance at the right time. Our out-of-the-box thinking helps clients navigate future uncertainties and market dynamics.
Contact for more Info:
AJ Daniel
Email: info@researchnester.com
U.S. Phone: +1 646 586 9123
U.K. Phone: +44 203 608 5919
- suraj333's blog
- Log in or register to post comments
